The Valley Desk

NCT07431281 · Interventional trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Overall registry status Recruiting

Phase 3

Conditions Esophageal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov